As depicted in Figure 9, OC exerts its anti-inflammatory and tumor-suppressive effects primarily through the downregulation of PAR-2 expression, thereby disrupting key oncogenic and inflammatory signaling cascades integral to CRC progression. The gene discussed is F2RL1; the disease is neoplasm.